Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
David Meeker
Biotech
Who's who of biotech execs back tiny Dutch rare disease startup
What links Ed Kaye, John Maraganore, David Meeker and a handful of other storied biopharma execs? They have all backed rare disease startup Xinvento.
Nick Paul Taylor
Apr 21, 2022 8:13am
Ex-Genzyme boss Meeker hops from KSQ to Rhythm Pharma
Jul 20, 2020 10:15am
As Rhythm Pharmaceuticals preps for first approval, CEO exits
Jan 7, 2020 7:50am
Ex-Blueprint R&D exec lands at KSQ Therapeutics
Apr 16, 2019 9:35am
Chutes & Ladders—David Meeker takes the helm at KSQ
Oct 5, 2017 3:40pm
KSQ raises $76M, names ex-Genzyme boss Meeker as CEO
Oct 2, 2017 7:00am
